Published in Invest New Drugs on January 01, 1999
Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J (2007) 2.91
The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors. Neoplasia (2005) 1.00
Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies. Int J Mol Sci (2014) 0.91
The role of epidermal growth factor receptor in photodynamic therapy: a review of the literature and proposal for future investigation. Lasers Med Sci (2010) 0.90
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization. J Cell Mol Med (2014) 0.86
The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells. Lasers Med Sci (2012) 0.84
Achondroplasia: Development, Pathogenesis, and Therapy. Dev Dyn (2016) 0.83
Post-acute response of 9L gliosarcoma to Photofrin-mediated PDT in athymic nude mice. Lasers Med Sci (2007) 0.82
A model for the pharmacological treatment of crouzon syndrome. Neurosurgery (2006) 0.80
Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model. Oncotarget (2015) 0.79
Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities. Pharmaceuticals (Basel) (2010) 0.79
Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response. Isr J Chem (2012) 0.78
Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas. World J Urol (2006) 0.78
Amphiphilic suramin dissolves Matrigel, causing an 'inhibition' artefact within in vitro angiogenesis assays. Int J Exp Pathol (2013) 0.77
Chemophototherapy: An Emerging Treatment Option for Solid Tumors. Adv Sci (Weinh) (2016) 0.77
PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR. Acta Pharm Sin B (2014) 0.75
New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst (1990) 23.46
Mechanisms of angiogenesis. Nature (1997) 18.04
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (1995) 15.15
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (1992) 10.10
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (1995) 9.84
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (1997) 7.66
Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem (1993) 7.16
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet (1982) 6.06
Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev (1994) 5.04
Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res (1976) 4.60
The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell (1994) 4.35
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J (1998) 4.14
fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev (1994) 3.02
Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res (1995) 2.50
Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res (1986) 2.45
Vascular development: cellular and molecular regulation. FASEB J (1997) 2.35
Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol (1992) 2.01
PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol (1994) 1.85
Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation (1995) 1.83
Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol (1990) 1.82
Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev (1996) 1.75
An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res (1997) 1.60
Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors. J Med Chem (1997) 1.38
Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J Natl Cancer Inst (1992) 1.38
Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol (1996) 1.35
Sites of photosensitization by derivatives of hematoporphyrin. Photochem Photobiol (1986) 1.32
Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res (1993) 1.21
MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer. Br J Cancer (1996) 1.16
Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res (1994) 1.16
Platelet-derived growth factor receptor alpha subunit deleted Patch mouse exhibits severe cardiovascular dysmorphogenesis. Teratology (1995) 1.09
Photodynamic therapy for palliation of locally recurrent breast carcinoma. J Clin Oncol (1987) 0.98
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane. Br J Cancer (1993) 0.97
In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor. J Pharmacol Exp Ther (1997) 0.93
Receptor tyrosine kinase signaling in vascular development. Cell Growth Differ (1997) 0.91
Photodynamic therapy for chest wall recurrence in breast cancer. Int J Radiat Oncol Biol Phys (1991) 0.89
An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer (1993) 0.87
Evidence against the production of superoxide by photoirradiation of hematoporphyrin derivative. Photochem Photobiol (1984) 0.86
Whole bladder photodynamic therapy for transitional cell carcinoma of bladder. Urology (1985) 0.86
Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients. J Clin Oncol (1983) 0.85
Cancer metastasis: a search for therapeutic inhibition. Cancer Invest (1998) 0.83
Strategies for the discovery of novel tyrosine kinase inhibitors with anticancer activity. Anticancer Drug Des (1994) 0.81
The response of the rat urinary bladder microcirculation to photodynamic therapy. J Urol (1989) 0.80
Ovarian cancer patients with high CA-125 but no symptoms--should antiangiogenic treatments be considered? Oncol Res (1997) 0.78
Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro. J Med Chem (1996) 0.78
Development of angiogenesis inhibitors for cancer therapy. Invest New Drugs (1997) 0.78
Palliation of esophageal carcinoma. Laser and photodynamic therapy. Chest Surg Clin N Am (1994) 0.77
Phthalocyanine photodynamic therapy of experimental iris neovascularization. Ophthalmology (1991) 0.77
Photodynamic therapy: applications in bladder cancer and other malignancies. J Formos Med Assoc (1997) 0.77
Treatment of experimental preretinal neovascularization using photodynamic thrombosis. Invest Ophthalmol Vis Sci (1991) 0.76
Photodynamic therapy: status and potential. Oncology (Williston Park) (1989) 0.76
Photodynamic therapy for early stage lung cancer. Preferable to resection? Chest (1992) 0.75
Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitors. Anticancer Drug Des (1996) 0.75
In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors. Biochem Pharmacol (1996) 0.75
Inhibitors of angiogenesis in a clinical perspective. Anticancer Drugs (1996) 0.75
SGD: Saccharomyces Genome Database. Nucleic Acids Res (1998) 20.26
Integrating functional genomic information into the Saccharomyces genome database. Nucleic Acids Res (2000) 18.52
Using the Saccharomyces Genome Database (SGD) for analysis of protein similarities and structure. Nucleic Acids Res (1999) 13.65
ArrayExpress--a public database of microarray experiments and gene expression profiles. Nucleic Acids Res (2006) 8.92
ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res (2005) 6.73
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev (2001) 6.36
Telephone triage of acute illness by a practice nurse in general practice: outcomes of care. Br J Gen Pract (1998) 5.71
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Penicillin-binding proteins of penicillin-susceptible and intrinsically resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother (1980) 4.80
Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res (1976) 4.60
How does photodynamic therapy work? Photochem Photobiol (1992) 4.49
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation (1989) 4.32
Photoradiation therapy for the treatment of malignant tumors. Cancer Res (1978) 4.01
In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A (2000) 3.80
Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A (1986) 3.78
Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med (1976) 3.60
Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res (1997) 3.55
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2001) 3.17
Prevalence of anaemia in pregnant & lactating women in India. Indian J Med Res (2006) 3.04
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A (1998) 2.86
Primordial carbonylated iron-sulfur compounds and the synthesis of pyruvate. Science (2000) 2.81
Saccharomyces Genome Database provides tools to survey gene expression and functional analysis data. Nucleic Acids Res (2001) 2.71
The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns (1999) 2.58
Nonparametric simulation-based statistics for detecting linkage in general pedigrees. Am J Hum Genet (1996) 2.57
Hydrophilicity of a single residue within MscL correlates with increased channel mechanosensitivity. Biophys J (1999) 2.54
Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res (1979) 2.51
Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J Med Genet (1993) 2.50
Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol (1987) 2.50
Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry (1991) 2.49
Extracapsular cataract extraction in Nepal. 2-year outcome. Arch Ophthalmol (1991) 2.48
Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect (2001) 2.47
Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun (1996) 2.44
Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension. J Glaucoma (2001) 2.43
Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res (1985) 2.43
[Not Available]. J Minim Access Surg (2008) 2.41
Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem (1999) 2.38
Specificity of DNA uptake in genetic transformation of gonococci. Biochem Biophys Res Commun (1979) 2.34
The psychological impact of mammographic screening. A systematic review. Psychooncology (2005) 2.33
Factors influencing pneumothorax rate at lung biopsy: are dwell time and angle of pleural puncture contributing factors? Radiology (2001) 2.29
Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst (1986) 2.27
Laparoscopic repair of incarcerated ventral abdominal wall hernias. Hernia (2008) 2.21
Use of ethnographic methods for applied research on diabetes among the Ojibway-Cree in northern Ontario. Health Educ Q (1996) 2.16
The TOGp protein is a new human microtubule-associated protein homologous to the Xenopus XMAP215. J Cell Sci (1998) 2.16
Heat flow and distribution during induction of general anesthesia. Anesthesiology (1995) 2.12
Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun (2000) 2.07
Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation (1998) 2.06
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res (1995) 2.05
Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol (1992) 2.01
Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res (1981) 2.01
Angelman syndrome: mimicking conditions and phenotypes. Am J Med Genet (2001) 2.00
Homology-based annotation yields 1,042 new candidate genes in the Drosophila melanogaster genome. Nat Genet (2001) 1.97
Bacterial perturbation of cytokine networks. Infect Immun (1998) 1.96
Case report. Metastatic pulmonary calcification in renal failure: a new HRCT pattern. Br J Radiol (2002) 1.95
Evaluation of a district growth screening programme: the Oxford Growth Study. Arch Dis Child (1993) 1.94
Collagen-induced arthritis in the rat: modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum. Immunology (1981) 1.92
Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry (2004) 1.92
Psychoeducational intervention for caregivers of Indian patients with schizophrenia: a randomised-controlled trial. Acta Psychiatr Scand (2009) 1.90
Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart (2007) 1.90
Septic arthritis of the shoulder in adults. J Bone Joint Surg Am (1989) 1.88
Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes (2001) 1.81
Laparoscopic ventral hernia repair. J Laparoendosc Adv Surg Tech A (2000) 1.80
Vertical transmission of Salmonella paratyphi A. Indian J Pediatr (2007) 1.80
Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc Natl Acad Sci U S A (1987) 1.80
Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc Natl Acad Sci U S A (1986) 1.79
Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst (1975) 1.72
Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12. Antimicrob Agents Chemother (1988) 1.70
Vascularized bone flaps versus nonvascularized bone grafts for mandibular reconstruction: an outcome analysis of primary bony union and endosseous implant success. Head Neck (1999) 1.70
Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J Clin Endocrinol Metab (1998) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Adaptation of beta-cell mass to substrate oversupply: enhanced function with normal gene expression. Am J Physiol Endocrinol Metab (2001) 1.67
Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro. J Virol (1997) 1.65
Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. Cancer (1993) 1.62
Pyomyositis. A clinico-pathological study based on 19 autopsy cases, Mulago Hospital 1964-1968. East Afr Med J (1970) 1.62
Membrane permeability changes associated with DNA gyrase inhibitors in Escherichia coli. Antimicrob Agents Chemother (1985) 1.61
Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J Intern Med (2012) 1.60
Parent and sibling influences on adolescent alcohol use and misuse: evidence from a U.S. adoption cohort. J Stud Alcohol (1996) 1.60
An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res (1997) 1.60
Neutrophils: Cinderella of innate immune system. Int Immunopharmacol (2010) 1.59
Position statement and guidelines on unmodified electroconvulsive therapy. Indian J Psychiatry (2012) 1.58
Emerging & re-emerging infections in India: an overview. Indian J Med Res (2013) 1.57
Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene (2006) 1.57
Airway narrowing in porcine bronchi with and without lung parenchyma. Eur Respir J (2005) 1.57
Alcohol ablation of symptomatic vertebral hemangiomas. AJNR Am J Neuroradiol (1999) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J Biol Chem (1997) 1.55
Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels. Antimicrob Agents Chemother (1989) 1.55
Endoscopic visualisation to aid deep anterior lamellar keratoplasty. Eye (Lond) (2004) 1.54
Oxidative stress and ATPase6 mutation is associated with primary ovarian insufficiency. Arch Gynecol Obstet (2010) 1.54
Malignant fibrous histiocytoma: an institutional review. Cancer Invest (2001) 1.54
Cell-cycle regulatory sequences in a hamster histone promoter and their interactions with cellular factors. Nature (1987) 1.54
Genetic diversity of Vibrio cholerae in Chesapeake Bay determined by amplified fragment length polymorphism fingerprinting. Appl Environ Microbiol (2000) 1.53
Sleep deprivation induces excess diuresis and natriuresis in healthy children. Am J Physiol Renal Physiol (2011) 1.53
Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. J Med Chem (1996) 1.52
Orthopaedic residency training: a survey of the graduates' perspective. J Orthop Sports Phys Ther (1999) 1.51
The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ. Acta Psychiatr Scand (2009) 1.51